Star Combo receives TGA approval on proprietary ingredient InuFructis

Sydney-based health and nutrition manufacturer Star Combo Pharma has announced that its proprietary natural sweetener, InuFructis, has received approval from the Therapeutic Goods Administration (TGA) as a Proprietary Ingredient under the “flavour” category, effective 25 August 2025 Australian Manufacturing Forum. This milestone reflects the company’s dedication to scientific innovation and regulatory compliance, enabling the ingredient’s official entry into the market. With TGA backing, Star Combo is well-positioned to advance its product offerings and potentially expand its reach within the competitive health products landscape.

Read the full article on @AuManufacturing.